MY187735A - Compositions and methods for treating hepatitis c virus - Google Patents
Compositions and methods for treating hepatitis c virusInfo
- Publication number
- MY187735A MY187735A MYPI2014001520A MYPI2014001520A MY187735A MY 187735 A MY187735 A MY 187735A MY PI2014001520 A MYPI2014001520 A MY PI2014001520A MY PI2014001520 A MYPI2014001520 A MY PI2014001520A MY 187735 A MY187735 A MY 187735A
- Authority
- MY
- Malaysia
- Prior art keywords
- virus
- subject
- effective amount
- methods
- hepatitis
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 6
- 241000711549 Hepacivirus C Species 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 abstract 2
- 239000002552 dosage form Substances 0.000 abstract 2
- 229960000329 ribavirin Drugs 0.000 abstract 2
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161564500P | 2011-11-29 | 2011-11-29 | |
| PCT/US2012/055621 WO2013040492A2 (en) | 2011-09-16 | 2012-09-14 | Methods for treating hcv |
| US201261707459P | 2012-09-28 | 2012-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY187735A true MY187735A (en) | 2021-10-15 |
Family
ID=48803225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2014001520A MY187735A (en) | 2011-11-29 | 2012-11-27 | Compositions and methods for treating hepatitis c virus |
Country Status (4)
| Country | Link |
|---|---|
| AP (1) | AP2014007699A0 (es) |
| EC (1) | ECSP21087299A (es) |
| IL (1) | IL232889A (es) |
| MY (1) | MY187735A (es) |
-
2012
- 2012-11-27 MY MYPI2014001520A patent/MY187735A/en unknown
- 2012-11-27 AP AP2014007699A patent/AP2014007699A0/xx unknown
-
2014
- 2014-05-29 IL IL232889A patent/IL232889A/en active IP Right Grant
-
2021
- 2021-12-02 EC ECSENADI202187299A patent/ECSP21087299A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL232889A (en) | 2016-07-31 |
| AP2014007699A0 (en) | 2014-06-30 |
| ECSP21087299A (es) | 2022-02-25 |
| IL232889A0 (en) | 2014-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014501133A1 (en) | Compositions and methods for treating hepatitis c virus | |
| PH12019500289A1 (en) | Vaccines directed against a human enteroviruses | |
| MY160130A (en) | Hepatitis c virus inhibitors | |
| TN2013000421A1 (en) | 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
| MX2012004032A (es) | Compuestos para el tratamiento de hepatitis c. | |
| TN2012000358A1 (en) | Hepatitis c virus inhibitors | |
| MX2013001579A (es) | Inhibidores del virus de la hepatitis c | |
| TN2012000264A1 (en) | Hepatitis c virus inhibitors | |
| TN2012000214A1 (en) | Hepatitis c virus inhibitors | |
| MX2011008045A (es) | Inhibidores del virus de la hepatitis c. | |
| MY152971A (en) | Hepatitis c virus inhibitors | |
| EP2555622A4 (en) | HEPATITIS C-VIRUS HEMMER | |
| MX2012003171A (es) | Novedosos inhibidores macrociclicos de la replicacion del virus de hepatitis c. | |
| MY202109A (en) | Viral replication inhibitors | |
| MX337936B (es) | Compuestos inhibidores del virus de la hepatitis c. | |
| MX2012008652A (es) | Terapias para tratar infeccion por virus de hepatitis c. | |
| AR088580A1 (es) | Metodos y composiciones para tratar el virus de la hepatitis c | |
| PH12013502177A1 (en) | Hepatitis c virus inhibitors | |
| NZ630831A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| RU2013120345A (ru) | Новые способы лечения инфекции, вызванной вирусом гепатита с | |
| MY187735A (en) | Compositions and methods for treating hepatitis c virus | |
| UA114097C2 (xx) | Композиція (варіанти) та спосіб (варіанти) лікування вірусного гепатиту с | |
| MA20150030A1 (fr) | Compositions et méthodes pour traiter le virus de l'hépatite c | |
| UA47947U (ru) | Способ лечения хронических вирусных гепатитов в и с у детей | |
| UA90646C2 (ru) | Способ лечения часто рецидивирующей хронической герпетической инфекции, вызванной вирусом герпеса простого и и ии типов |